Kallyope Funding & Investors
New York, NY
Kallyope, Inc. operates as a bio-technology company. The Company focuses on understanding gut-brain biology that will lead to transformational therapeutics to improve human health. Kallyope serves customers in the United States.
https://kallyope.com/Total Amount Raised: $487,200,000
Kallyope Funding Rounds
Grant
$8,200,000
Grant Investors
Bill & Melinda Gates FoundationSeries D
$236,000,000
Series D Investors
MubadalaThe Column GroupLux CapitalIllumina VenturesParkwoodAlexandria Venture InvestmentsDNS CapitalStepStone GroupHartford Healthcare EndowmentTwo Sigma VenturesTao Capital PartnersPolaris PartnersCasdin CapitalBill GatesEuclidean CapitalSeries C
$112,000,000
Series C Investors
Illumina VenturesGreenspring AssociatesPolaris PartnersCasdin CapitalThe Column GroupBill GatesEuclidean CapitalLux CapitalAlexandria Venture InvestmentsTwo Sigma VenturesSeries B
$21,000,000
Series B Investors
Bill GatesEuclidean CapitalIllumina VenturesAlexandria Venture InvestmentsThe Column GroupPolaris PartnersLux CapitalTwo Sigma VenturesSeries B
$66,000,000
Series B Investors
Lux CapitalAlexandria Venture InvestmentsThe Column GroupTwo Sigma VenturesPolaris PartnersEuclidean CapitalIllumina VenturesSeries A
$44,000,000
Series A Investors
Polaris PartnersLux CapitalThe Column GroupAnthony EvninAlexandriaIllumina Ventures
Funding info provided by Diffbot.